- Home
- NNY vs PROF Comparison
NNY vs PROF Comparison
Compare NNY & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNY
- PROF
- Stock Information
- Founded
- NNY 1987
- PROF N/A
- Country
- NNY United States
- PROF Canada
- Employees
- NNY N/A
- PROF N/A
- Industry
- NNY Investment Managers
- PROF Medical/Dental Instruments
- Sector
- NNY Finance
- PROF Health Care
- Exchange
- NNY Nasdaq
- PROF Nasdaq
- Market Cap
- NNY 152.8M
- PROF 134.3M
- IPO Year
- NNY N/A
- PROF N/A
- Fundamental
- Price
- NNY $8.19
- PROF $4.11
- Analyst Decision
- NNY
- PROF Strong Buy
- Analyst Count
- NNY 0
- PROF 1
- Target Price
- NNY N/A
- PROF $11.00
- AVG Volume (30 Days)
- NNY 50.9K
- PROF 167.1K
- Earning Date
- NNY 01-01-0001
- PROF 11-06-2025
- Dividend Yield
- NNY 4.04%
- PROF N/A
- EPS Growth
- NNY N/A
- PROF N/A
- EPS
- NNY N/A
- PROF N/A
- Revenue
- NNY N/A
- PROF $11,840,000.00
- Revenue This Year
- NNY N/A
- PROF $60.07
- Revenue Next Year
- NNY N/A
- PROF $121.80
- P/E Ratio
- NNY N/A
- PROF N/A
- Revenue Growth
- NNY N/A
- PROF 59.81
- 52 Week Low
- NNY $7.58
- PROF $3.90
- 52 Week High
- NNY $8.87
- PROF $9.17
- Technical
- Relative Strength Index (RSI)
- NNY 63.86
- PROF 30.34
- Support Level
- NNY $8.03
- PROF $4.38
- Resistance Level
- NNY $8.22
- PROF $4.69
- Average True Range (ATR)
- NNY 0.06
- PROF 0.21
- MACD
- NNY 0.01
- PROF -0.03
- Stochastic Oscillator
- NNY 86.36
- PROF 11.04
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.